文献速递妇科产科

高危子宫内膜癌前哨淋巴结定位联合或不联合补救性淋巴结清扫的多中心研究

Sentinel node mapping vs. sentinel node mapping plus back-up lymphadenectomy in high-risk endometrial cancer patients: Results from a multi-institutional study.
PubMed 文献 · Gynecol Oncol · 2021-01-20

这项国际多中心回顾性研究纳入196例高危子宫内膜癌患者,比较前哨淋巴结定位(SNM)单独使用与SNM联合补救性淋巴结清扫的结局。结果显示两种淋巴结评估方式在无病生存和总生存上无显著差异,补救性淋巴结清扫可额外检出阳性淋巴结,但其治疗价值仍存争议。

要点

  • 高危子宫内膜癌中,SNM单独与SNM联合补救性淋巴结清扫的生存结局相似。
  • 补救性淋巴结清扫可清除额外阳性淋巴结,但治疗价值尚不明确。
  • 研究样本量小且为回顾性设计,需进一步前瞻性证据。

核心结论

  • 在高危子宫内膜癌中,淋巴结评估方式(SNM单独或SNM联合补救性淋巴结清扫)未影响生存结局。
  • 补救性淋巴结清扫理论上有助于清除阳性淋巴结,但其治疗价值仍存争议。

研究设计与样本

  • 国际多中心回顾性研究,评估196例高危子宫内膜癌患者的数据。
  • 高危定义为FIGO 3级子宫内膜样癌伴肌层浸润>50%及非子宫内膜样组织学类型。
  • 50例接受SNM单独,146例接受SNM联合补救性淋巴结清扫。

主要发现

  • SNM单独组中14例(28%)诊断淋巴结病变。
  • SNM联合补救性淋巴结清扫组中34例(23.2%)通过SNM诊断淋巴结病变。
  • 补救性淋巴结清扫额外发现2例(1%)淋巴结病变(腹主动脉旁区域)。
  • 补救性淋巴结清扫使16例(11%)患者清除额外阳性淋巴结。
  • 倾向性匹配后,两组无病生存(p=0.416,log-rank检验)和总生存(p=0.940,log-rank检验)相似。

关键数值与推荐

  • 196例中83例为子宫内膜样癌,113例为非子宫内膜样癌。
  • SNM单独组淋巴结病变14例(28%),SNM联合补救性淋巴结清扫组经SNM诊断34例(23.2%)。
  • 补救性淋巴结清扫额外检出2例(1%)腹主动脉旁淋巴结病变,16例(11%)清除额外阳性淋巴结。
  • 倾向性匹配后无病生存p=0.416,总生存p=0.940(log-rank检验)。

临床怎么用

  • 高危子宫内膜癌患者可考虑SNM作为淋巴结评估方式,生存结局与联合补救性淋巴结清扫相似。
  • 补救性淋巴结清扫可提高阳性淋巴结清除率,但需权衡其治疗价值的不确定性。

局限性

  • 样本量小。
  • 回顾性研究设计。
  • 需进一步前瞻性证据验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Sentinel node mapping (SLN) has replaced lymphadenectomy for staging surgery in apparent early-stage low and intermediate risk endometrial cancer (EC). Only limited data about the adoption of SNM in high risk EC is still available. Here, we evaluate the outcomes of high-risk EC undergoing SNM (with or without back-up lymphadenectomy). METHODS: This is a multi-institutional international retrospective study, evaluating data of high-risk (FIGO grade 3 endometrioid EC with myometrial invasion >50% and non-endometrioid histology) EC patients undergoing SNM followed by back-up lymphadenectomy and SNM alone. RESULTS: Chart of consecutive 196 patients were evaluated. The study population included 83 and 113 patients with endometrioid and non-endometrioid EC, respectively. SNM alone and SNM followed by back-up lymphadenectomy were performed in 50 and 146 patients, respectively. Among patients having SNM alone, 14 (28%) were diagnosed with nodal disease. In the group of patients undergoing SNM plus back-up lymphadenectomy 34 (23.2%) were diagnosed with nodal disease via SNM. Back-up lymphadenectomy identified 2 (1%) additional patients with nodal disease (in the para-aortic area). Back-up lymphadenectomy allowed to remove adjunctive positive nodes in 16 (11%) patients. After the adoption of propensity-matched algorithm, we observed that patients undergoing SNM plus back-up lymphadenectomy experienced similar disease-free survival (p = 0.416, log-rank test) and overall survival (p = 0.940, log-rank test) than patients undergoing SLN alone. CONCLUSIONS: Although the small sample size, and the retrospective study design this study highlighted that type of nodal assessment did not impact survival outcomes in high-risk EC. Theoretically, back-up lymphadenectomy would be useful in improving the removal of positive nodes, but its therapeutic value remains controversial. Further prospective evidence is needed.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Bogani G, Papadia A, Buda A, et al. Sentinel node mapping vs. sentinel node mapping plus back-up lymphadenectomy in high-risk endometrial cancer patients: Results from a multi-institutional study. Gynecol Oncol. 2021. PMID: 33485641. doi:10.1016/j.ygyno.2021.01.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。